1st Circ. Revives Qui Tam Claims Over Procrit AWP
A federal appeals court has revived part of a whistleblower suit alleging Ortho Biotech Products LP inflated the average wholesale price of the anemia drug Procrit, spurring sales to medical providers...To view the full article, register now.
Already a subscriber? Click here to view full article